Henry-Amar, M.

patient disease radiotherapy chemotherapy trial treatment hodgkin group survival cancer cycle mopp-abv subtotal nodal radiotherapy lymphoma death h 8-u trial nodal involved-field radiotherapy stage h 8-f trial table involved-field study result subtotal remission netherland france if-rt relapse mortality cause oncol radiation estimate vinblastine prognostic bleomycin therapy prednisone randomization prognosis number procarbazine early-stage doxorubicin center medicine downloaded england journal university erasmus university response difference centre involvedfield radiotherapy factor event-free toxicity comparison vincristine analysis hodgkin lymphoma /favier outcome e ng l irradiation abnormality early-stage disease follow-up european organization progression risk factors probability organization j clin oncol research patients ages 15 model www.nejm.org disease progression journal